Sunday July 05 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

 

The SCBC 4th Annual Investment & Strategic Partnering Opportunities Conference

New Biotech And Medical Device Companies Compete For Investors' Attention During The SCBC 4th Annual Investment & Strategic Partnering Opportunities Conference

Forum Launches March 14-15, 2002

LOS ANGELES, CA -- (INTERNET WIRE) -- 03/04/2002 -- The Southern California Biomedical Council (SCBC) today finalized the list of biotech and medical device companies selected to present at its 4th Annual Investment & Strategic Partnering Opportunities Conference. This event will be held on March 14-15 at the Wilshire Grand Hotel in Downtown Los Angeles. To attend the SCBC Investor conference, you must pre-register at: www.socalbio.org/investor_conference_2002/Registration.htm.

The SCBC Investor Conference features business presentations by CEOs of early-stage and pre-IPO Southern California biotech and medical device firms interested in raising capital and/or forging strategic partnerships. Selected from a large pool of Southern California-based firms by an advisory board of seasoned business professionals, the following companies will have the opportunity to share their business plans with potential investors and partners:

      
** Arbios Technologies (Los Angeles, CA): Bioartificial liver
** AusAm Biotech (Santa Monica, CA): Novel drug compounds to treat
   kidney disease
** Calhoun Vision (Pasadena, CA): Intraocular lens that can be 
   adjusted non-invasively while in the eye 
** Chemokine Inc. (Irvine, CA): Drugs to stop cancer cells from spreading 
** Epeius Biotechnologies (Los Angeles, CA):
 Therapies for metastatic colorectal cancer and other malignant solid tumors 
** GeneFuildics (Monterey Park, CA): MEMS-based gene analysis devices 
** Glaukos (Laguna Niguel, CA): Implantable device to treat Glaucoma 
** HemaVation (Costa Mesa, CA): Device to treat acute renal failure (ARF) and septicemia 
** Ionian Technologies (Claremont, CA): Novel genotyping technology 
** Medical Tactile Inc. (Los Angeles, CA): Device for early detection of breast cancer 
** MicroSolutions (Santa Barbara, CA): Proprietary drug delivery technology to improve chronic disease management 
** Mpex BioScience (San Diego, CA): Discovery and development of novel therapeutics for membrane protein disease targets 
** Pacific Wave Biomedical Innovations (Los Angeles, CA) : MEMS-based fiber optic photonic sensors for medical applications 
** Pivotal Machines (Cerritos, CA): Microfluidic flow injection immunoassays 
** Plexus Vaccine, Inc. (San Diego, CA): Rational vaccine design & development 
** Pranalytica, Inc. (Santa Monica, CA): Development of a CO2 laser- based sensing technology for medical applications 
** Orqis Medical (Lake Forest, CA): Cardiac recovery device to meet the needs of CHF patients 
** Q-Step (La Crescenta, CA): Non-invasive bio-photonic device to monitor the blood glucose levels of diabetics 
** Refractec (Irvine, CA): Radio frequency instrument for treating far-sightedness 
** StemSource (Westlake Village, CA): Stem cells for the emerging cell therapy and tissue engineering industry 

“The SCBC is pleased to work with leading investors, such as Versant Ventures, and service providers, such as KPMG LLP and Lyon & Lyon LLP, in organizing this annual forum for emerging firms to exchange information with potential investors and partners. It is a win-win situation for all parties involved. CEOs of selected companies will get a chance to network and promote their companies to potential investors. Investors, analysts and reporters will get a closer look at new technologies under development by a new generation of Southern California-based firms,” said Alfred E. Mann, Conference Co-chair, Chairman of the Southern California Biomedical Council, and founder of numerous LA-based biotech and device firms, such as Mannkind, MiniMed (now part of Medtronic), Advanced Bionics, and Second Sight.

The SCBC Investor Conference will also showcase the following new Southern California-based venture funds that invest in life science companies:

   
** Coastview Capital (Los Angeles & Westlake Village, CA)
** Convergent Ventures (Los Angeles, CA)
** HamiltonApex Technology Ventures (San Diego, CA)
   

In addition, the SCBC Investor Conference will feature over 40 venture capitalists, investment bankers, and biomed/biotech executives participating in different panel discussions, symposia and workshops. These panels, symposia, and workshops -- moderated by seasoned professionals from service providers such as Deloitte & Touche, Ernst & Young, Heller Ehrman White & McAuliffe, KPMG, Lyon & Lyon, Perkins Coie, Roth Capital Partners, and Versant Ventures -- are designed to be interactive and cover issues of interest to pre-IPO companies and early-stage investors, from the nuts and bolts of negotiating terms sheets and closing a private equity deal, to the ingredients of building a successful biotech or device company.

The SCBC Investor Conference boasts a high-profile and respected list of sponsors, each of whom have contributed financially as well as hours of volunteer time coaching presenters and acting as mentors. These sponsors include:

    
** Platinum Sponsors: 
KPMG LLP
Lyon & Lyon LLP
    
** Gold Sponsors: 
Deloitte & Touche LLP
Ernst & Young LLP
Heller Ehrman White & McAuliffe
Perkins Coie LLP
Roth Capital Partners
Versant Ventures
    
** Silver Sponsors: 
Bench International
Bolton & Company
Brobeck, Phleger & Harrison LLP
Colliers Seeley
Convergent Ventures, LLC 
Crosby, Heafey, Roach & May
Sidley Austin Brown & Wood
Southland Industries
Summit Corporate Partners
    
** Associated Sponsors: 
California Manufacturing Technology Center (CMTC)
California State University Program for Education & Research in Biotechnology (CSUPERB)
LA Economic Development Corp. (LAEDC)
    

The Southern California Biomedical Council (SCBC) is a trade association focused on promoting biomed/biotech business development in the greater Los Angeles region. For more information, please visit the Web at: www.socalbio.org, or contact the SCBC at 213-236-4890.

Contact: Ahmed Enany
Company: Southern California Biomedical Council
Title: President & CEO
Phone: 213-236-4890
Email: scbc@socalbio.org
URL: http://www.socalbio.org

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.